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1 These safety procedures refer to the small preliminary donation
made on site. This is firstly cross-matched for compatibility with
the intended recipient, if the donor is suitable the blood sample is
then screened for the listed infectious agents. It is only those
individuals who are clear of infection and compatible with the
recipient who are call upon for a larger collection for the purpose
of transfusion.
Introduction
The Republic of  South Sudan gained independence in July 
2011 after nearly two decades of  civil war.  The increase 
in cross border traffic following independence and the 
return of  displaced nationals, may have unforeseen effects 
on the health of  the population. The pattern of  diseases 
across East Africa is defined by infectious conditions 
such as malaria and HIV. It has been suggested that the 
relocation of  individuals from hyperendemic countries, 
such as Uganda, may influence the prevalence rates of  
these infections in South Sudan.
This research focused on the viral transfusion transmissible 
infections (VTTI), Hepatitis B and C, and HIV.  Little is 
known about the level of  these infections in South Sudan, 
although details from neighbouring countries would 
suggest that both HIV and Hepatitis B are endemic. 
Objectives
To determine the prevalence of  HBSAg, HCV and HIV 
among blood donors in Maridi between January 2007 
and December 2011 and make recommendations on 
prevention and treatment options.
Methodology
This retrospective study reviewed the records of  volunteer 
adult blood donors from the Maridi County Hospital 
laboratory from 2007-2011. Data was anonymised. The 
statistical analysis calculated 95% confidence intervals 
with significance taken as p ≤ 0.05 using a Fishers Exact 
test.
Ethical approval for this research was provided by 
the ethical committee in the Office of  the Director of  
Research, Monitoring and Evaluation, Ministry of  Health, 
which was shared with the State Ministry of  Health and 
the County Health Department.
Setting
Maridi County borders the Demographic Republic of  
Congo to the south. The projected population of  Maridi 
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is 108,629 based on the 2008 national population census 
results (with 3% annual population growth and returnees 
factored in). The population is served by a network of  3 
Primary Health Care Centres (PHCCs), twenty Primary 
Health Care Units (PHCUs) and by Maridi County 
hospital.  Maridi hospital admits 4,000-5,000 patients 
annually. Admissions are triaged to assess the need for 
a blood transfusion, with common causes being injury, 
anaemia attributed to malaria and obstetric emergencies. 
There is no blood bank in Maridi hospital.  A blood donation 
is requested from the family when the haemoglobin is 
below 4g/dl without any other symptoms or 4-6g/dl with 
clinical features of  hypoxia, acidosis, hyperparasitaemia of  
more than 20% and impaired consciousness [1].  Following 
standard safety procedures1  the preliminary donation is 
made onsite before the sample is cross-matched for blood 
type, only those compatible samples are then screened for 
viral infections.
A number of  rapid serological tests for transfusion 
transmissible viral infections are available onsite, supplied 
by the United Nations Development Programme 
(UNDP) under the Global Fund. These tests include 
the Hepatitis B surface antigen (HBsAg) rapid Dip-strip 
(Acon Laboratories Inc), Hepatitis C virus (HCV) rapid 
test (Span Diagnostics, Ltd), Determine HIV1/2 test 
strips (Alere Medical Co.) and UniGold HIV1/2 (Trinity 
Biotech Plc).  All compatible blood samples are screened 
with all four tests, and only those deemed to be safe and 
uninfected are utilised for the transfusion.
Results
Over the 5 years (2007-2011) 324 individuals received a 
blood transfusion. The most common recipients were 
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children under the age of  five (183/324) and women over 
16 years of  age (80/324).
In the same time period, records exist for 496 blood 
donations. The mean age of  donors was 28 years (range 
of  16-58) (Figure 1a). The representation of  the different 
blood groups, rounded to the nearest decimal point was A 
26.4%; B 15.7%; AB 1.4% and O 56.4%.  Men were more 
likely to donate than women (322/496).  
Within this donor population 110/496 donors were found 
to be infected with antigens for at least one VTTI, of  
which 13 were mixed infections (11.8%, 95% confidence 
interval (CI) = 5.8-17.8%) and 97 were single infections 
(88.2%, CI = 82.1-94.2%), no triple infections were 
detected (see Figure 2).  In terms of  diagnostic events, 
Hepatitis C seropositivity was 9.3% (CI = 6.7-11.8%), 
Hepatitis B surface antigen at 8.9% (CI = 6.4-11.4%) and 
HIV at 6.7% (CI = 4.5-8.8%), see Figure 2.
The prevalence of  transfusion transmissible infections in 
male blood donors was 74/322 (23.0%, CI = 18.3-27.6%) 
compared to 36/174 (20.7%, CI = 14.7-26.7%) in female 
donors, however there is no significant difference between 
the sexes (Fishers exact test, p=0.57).  In terms of  age 
analysis, 25 individuals were discounted as the age was not 
recorded, one of  these was found to have antigens for 
HCV. Of  the remaining cohort two thirds (77/109) of  the 
infections were among the age bracket of  21-35 years (see 
Figure 1b), no statistical differences occurred between the 
genders at any age group. 
Discussion
The age of  blood donors seems to be weighted towards 
those individuals of  less than 40 years of  age This 
distribution is in keeping with that of  the country’s 
population structure more generally where prolonged 
civil unrest has left 79% of  the population being less 
than 30 years old [2]. The demography of  blood group 
distribution within the studied population is not dissimilar 
to the most recent information available from Sudan, the 
main differences being due to the low representation of  
AB (1.4 %) compared to a country wide average of  7% 
[3].
Of  the 496 blood donors, only 174 were females.  This 
gender bias may reflect that one of  the main conditions 
requiring a blood transfusion was a complication of  child 
birth.  The immediate donors are usually the spouse which 
may address why the number of  male blood donors is 
higher than females.  Culturally and socially, it is also 
reported to be more acceptable for the blood donation to 
be made by a male member of  the family [4].
HIV was reported at 6.7%. This is twice the national 
average reported from antenatal clinics (ANC) across 
the country in 2009 [5], and is similar to findings from 
the 2011 National HIV indicator survey from Uganda 
[6].  Information from the Western Equatoria State also 
indicate an increase in the recorded occurrence of  HIV. A 
study in 2012 from ANC and voluntary counselling and 
testing facilities reported a seropositivity of  12.1% (CI = 
9.6-14.1%) [7]. 
Sudan has been classified as a country with high endemicity 
of  Hepatitis B virus (HBV), historically rated at 8% in 
1996 by the World Health Organisation [8].  In keeping 
with our findings the situation appears largely unchanged 
with the seroprevalence in eastern Sudan reported at 8.2% 
(n = 376) [9], 5.1% in the north of  the country [10] and 
5.6% in the central regions [11]. However caution has 
been urged regarding the sole reliance on HBsAg for 
the detection of  this infectious agent, with an increased 
sensitivity reported when the core antigen is used as a the 
diagnostic target [12].
The seroprevelence of  Hepatitis C found in this study is 
Figure 1: Population pyramids (a) for the blood donation cohort of know age (n=471), (b) based on the population VTTI prevalence with 
95% confidence intervals.  
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significantly higher than that of  previous reports (Fishers 
exact test, p <0.0001), for example in South Darfur state 
in 2009 the detected prevalence amongst 400 male blood 
donors was 0.65% [4], while in southern Sudan 3% of  
666 outpatients subjects were positive for anti-HCV 
antibodies [13].  Unpublished work reported suggests a 
seroprevalence in asymptomatic blood donors of  4.4%, 
but no other details are forthcoming [14].
It is too early to determine if  the disease landscape will 
alter in South Sudan with the return of  peace. However, 
this research provides a useful baseline upon which to 
base further studies, and highlights the need for awareness 
of  the risk of  transmission.  The elevated level of  HCV 
within this studied population highlights the need for 
further investigation, while HBV prevalence can be 
targeted with the incorporation of  vaccination into the 
routine expanded programme of  immunisation across the 
country. 
Conclusion
This study provides an insight into the prevalence of  these 
viral infections within the community local to Maridi 
hospital. It reaffirms the need for continued surveillance 
of  blood donations prior to use.  Sustained health care 
promotion, the availability of  treatment, health promotion 
and appropriate management must be ensured to prevent 
the further transmission of  these infections.  
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